Pharmacyclics Cash and ST Investments:
511.25M for Sept. 30, 2012Pharmacyclics Historical Cash and ST Investments Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 511.25M |
| Sept. 30, 2012 | 286.10M |
| June 30, 2012 | 203.61M |
| March 31, 2012 | 214.96M |
| Dec. 31, 2011 | 240.33M |
| Sept. 30, 2011 | 105.25M |
| June 30, 2011 | 112.33M |
| March 31, 2011 | 54.41M |
| Dec. 31, 2010 | 61.61M |
| Sept. 30, 2010 | 67.77M |
| June 30, 2010 | 74.15M |
| March 31, 2010 | 27.39M |
| Dec. 31, 2009 | 30.12M |
| Sept. 30, 2009 | 33.87M |
| June 30, 2009 | 16.33M |
| March 31, 2009 | 11.46M |
| Dec. 31, 2008 | 12.92M |
| Sept. 30, 2008 | 12.47M |
| June 30, 2008 | 16.76M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
Learn More
PCYC Cash and ST Investments Benchmarks
| Companies | |
|---|---|
| Endo Health Solutions | 340.52M |
| Gilead Sciences | 2.631B |
| Salix Pharmaceuticals | 751.01M |
PCYC Cash and ST Investments Rankings
| Overall |
90th percentile 744 of 7593 |
| Sector |
90th percentile 61 of 650 in Healthcare |
| Industry |
92nd percentile 5 of 65 in Drug Manufacturers - Specialty & Generic |
PCYC Cash and ST Investments Range, Past 5 Years
| Minimum | 11.46M | Mar 2009 |
| Maximum | 511.25M | Mar 2013 |
| Average | 110.16M |
